Company
Vivodyne
Make biology computable
Also known as Vivodyne, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Francisco, United States
- Customers
- leading biopharmas
- Legal name
- Vivodyne, Inc.
- vivodyne.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We train biological superintelligence to collapse the time from therapeutic hypothesis to validated human efficacy to zero.
Funding snapshot
- Total raised
- $79.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $40M2025-05-29
Funding rounds
- Series A
- $40M2025-05-29, Company stated
- Round, 2025
- $77.7M2025-02-03, SEC form D sold, 18 investors
- Round, 2021
- $2M2021-03-04, SEC form D sold, 1 investor
Products
- Hardware
- HIVE
- Hardware
- Vivodyne TissueDisk
Loading relationship preview